Page 94 - 01.pdf

NOTES TO THE
FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2013
34. FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES (Continued)
Liquidity risk (Continued)
One year
or less
One to
five years Total
$ $ $
Company
2012
Financial assets:
Trade receivables 1,896,583 – 1,896,583
Other receivables 240,247 – 240,247
Cash and short term deposits 7,734,459 – 7,734,459
Total undiscounted financial assets 9,871,289 – 9,871,289
Financial liabilities:
Trade payables 37,280 – 37,280
Other payables and accruals 386,142 – 386,142
Total undiscounted financial liabilities 423,422 – 423,422
Total net undiscounted financial assets 9,447,867 – 9,447,867
35. CAPITAL MANAGEMENT
The Group reviews and manages its capital structure to ensure optimal capital structure to maximise
shareholder’s returns taking into consideration the future capital requirements of the Group and capital efficiency,
prevailing and projected profitability, projected operating cash flows, projected capital expenditures and projected
strategic investment opportunities. To maintain or adjust the capital structure, the Group may adjust the dividend
payment to shareholders, return capital to shareholders or issue new shares. No changes were made in the
objectives, policies or processes during the years ended 31 December 2013 and 31 December 2012.
36. AUTHORISATION OF FINANCIAL STATEMENTS FOR ISSUE
The financial statements for the year ended 31 December 2013 were authorised for issue in accordance with
a resolution of the Directors on 31 March 2014.
ASIAMEDIC LIMITED
ANNUAL REPORT 2013 92